OR | 95% CI | |
Sex (male) | 2.1 | 0.09–47.93 |
CD4 <200 | 5.1 | 0.41–63.09 |
Use of nucleoside analogous | 0.5 | 0.06–4.78 |
Sensitivity test# | ||
Multidrug resistance | 11.1 | 0.15–797.1 |
Not assessed | 0.1 | 0.00–3.19 |
Atypical chest radiograph | 7.2 | 0.43–119.1 |
Modified treatment | 0.3 | 0.00–11.75 |
Treatment complications | 7.4 | 0.73–75.97 |
Nonadherence | 29.2 | 2.43–350.1 |
OR: odds ratio
CI: confidence interval
CD4: helper cell count
#: in comparison with no multidrug resistance